These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 25995635)
1. Hydroxypropyl-β-cyclodextrin functionalized calcium carbonate microparticles as a potential carrier for enhancing oral delivery of water-insoluble drugs. Zhang L; Zhu W; Lin Q; Han J; Jiang L; Zhang Y Int J Nanomedicine; 2015; 10():3291-302. PubMed ID: 25995635 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes. Patel SG; Rajput SJ AAPS PharmSciTech; 2009; 10(2):660-9. PubMed ID: 19459053 [TBL] [Abstract][Full Text] [Related]
3. Exploring the interactions of irbesartan and irbesartan-2-hydroxypropyl-β-cyclodextrin complex with model membranes. Liossi ΑS; Ntountaniotis D; Kellici TF; Chatziathanasiadou MV; Megariotis G; Mania M; Becker-Baldus J; Kriechbaum M; Krajnc A; Christodoulou E; Glaubitz C; Rappolt M; Amenitsch H; Mali G; Theodorou DN; Valsami G; Pitsikalis M; Iatrou H; Tzakos AG; Mavromoustakos T Biochim Biophys Acta Biomembr; 2017 Jun; 1859(6):1089-1098. PubMed ID: 28274845 [TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129 [TBL] [Abstract][Full Text] [Related]
5. Influence of hydrophilic additives on the supersaturation and bioavailability of dutasteride-loaded hydroxypropyl-β-cyclodextrin nanostructures. Kim MS Int J Nanomedicine; 2013; 8():2029-39. PubMed ID: 23737668 [TBL] [Abstract][Full Text] [Related]
6. Inclusion Complexes of Hydroxy Propyl-β-Cyclodextrin and Paliperidone: Preparation and Characterization. Sherje A; Londhe V Curr Drug Discov Technol; 2014; 11(4):271-8. PubMed ID: 25578059 [TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β-cyclodextrin-in-liposome. Wang X; Deng L; Cai L; Zhang X; Zheng H; Deng C; Duan X; Zhao X; Wei Y; Chen L J Pharm Sci; 2011 Aug; 100(8):3357-3364. PubMed ID: 21387317 [TBL] [Abstract][Full Text] [Related]
8. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability. Jain S; Reddy VA; Arora S; Patel K Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488 [TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin. Liu M; Cao W; Sun Y; He Z Int J Pharm; 2014 Dec; 477(1-2):159-66. PubMed ID: 25455768 [TBL] [Abstract][Full Text] [Related]
10. Spray dried nanospheres for inclusion complexes of cefpodoxime proxetil with β-cyclodextrin, 2-hydroxypropyl-β-cyclodextrin and methyl-β-cyclodextrin: improved dissolution and enhanced antibacterial activity. Yurtdaş-Kırımlıoğlu G Drug Dev Ind Pharm; 2021 Aug; 47(8):1261-1278. PubMed ID: 34606394 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of solubility and permeability of Candesartan cilexetil by using different pharmaceutical interventions. Shaikh SM; Avachat AM Curr Drug Deliv; 2011 Jul; 8(4):346-53. PubMed ID: 21453263 [TBL] [Abstract][Full Text] [Related]
12. Antihypertensive activity and molecular interactions of irbesartan in complex with 2-hydroxypropyl-β-cyclodextrin. Leonis G; Christodoulou E; Ntountaniotis D; Chatziathanasiadou MV; Mavromoustakos T; Naziris N; Chountoulesi M; Demetzos C; Valsami G; Damalas DE; Tzakos AG; Thomaidis NS; Karageorgos V; Liapakis G Chem Biol Drug Des; 2020 Jul; 96(1):668-683. PubMed ID: 32691965 [TBL] [Abstract][Full Text] [Related]
13. Preparation of curcumin-hydroxypropyl-β-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug. Li N; Wang N; Wu T; Qiu C; Wang X; Jiang S; Zhang Z; Liu T; Wei C; Wang T Drug Dev Ind Pharm; 2018 Dec; 44(12):1966-1974. PubMed ID: 30059244 [TBL] [Abstract][Full Text] [Related]
14. Candesartan Cilexetil Formulations in Mesoporous Silica: Preparation, Enhanced Dissolution In Vitro, and Oral Bioavailability In Vivo. Guan H; Wang M; Yu S; Wang C; Chen Q; Chen Y; Zhang W; Fan J J Pharm Sci; 2024 Oct; 113(10):3045-3053. PubMed ID: 39094942 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin. Nie S; Fan X; Peng Y; Yang X; Wang C; Pan W Arch Pharm Res; 2007 Aug; 30(8):991-1001. PubMed ID: 17879753 [TBL] [Abstract][Full Text] [Related]
16. Influence of levodropropizine and hydroxypropyl-β-cyclodextrin association on the physicochemical characteristics of levodropropizine loaded in hydroxypropyl-β-cyclodextrin microcontainers: Formulation and in vitro characterization. Yousaf AM; Qadeer A; Raza SA; Chohan TA; Shahzad Y; Din FU; Khan IU; Hussain T; Alvi MN; Mahmood T Polim Med; 2019; 49(1):35-43. PubMed ID: 31769938 [TBL] [Abstract][Full Text] [Related]
17. Ternary system of dihydroartemisinin with hydroxypropyl-β-cyclodextrin and lecithin: simultaneous enhancement of drug solubility and stability in aqueous solutions. Wang D; Li H; Gu J; Guo T; Yang S; Guo Z; Zhang X; Zhu W; Zhang J J Pharm Biomed Anal; 2013 Sep; 83():141-8. PubMed ID: 23732534 [TBL] [Abstract][Full Text] [Related]
18. Preformulation study of the inclusion complex irbesartan-beta-cyclodextrin. Hirlekar R; Kadam V AAPS PharmSciTech; 2009; 10(1):276-81. PubMed ID: 19283492 [TBL] [Abstract][Full Text] [Related]
19. Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin. Miyake K; Arima H; Hirayama F; Yamamoto M; Horikawa T; Sumiyoshi H; Noda S; Uekama K Pharm Dev Technol; 2000; 5(3):399-407. PubMed ID: 10934740 [TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin. Liu J; Qiu L; Gao J; Jin Y Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]